[II. New Treatment Option for Acute Lymphoblastic Leukemia]
Gan To Kagaku Ryoho
.
2018 May;45(5):801-805.
[Article in Japanese]
Authors
Junya Makiyama
1
,
Arinobu Tojo
Affiliation
1
Dept. of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo.
PMID:
30026441
No abstract available
MeSH terms
Antineoplastic Agents / therapeutic use*
Humans
Immunotherapy
Molecular Targeted Therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Substances
Antineoplastic Agents